Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Chiariello

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancers|October 13, 2021
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical ModelsLisa Gherardini, Giovanni Inzalaco, Francesco Imperatore, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2Mario Acunzo, Giulia Romano, Dario Palmieri, et al.
Autophagy|November 14, 2017
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2BDavid Colecchia, Mariangela Stasi, Margherita Leonardi, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Biomaterials Science|March 10, 2026
Nanocellulose with dual carboxy and aldehyde functionality: a modular platform for hydrogel formation and sustained drug releaseEmanuela Bua, Chiara Spanu, Giovanni Inzalaco, et al.
Oncotarget|March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumorsMatteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Journal of Medicinal Chemistry|May 5, 2017
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain BarrierIlaria Monaco, Simona Camorani, David Colecchia, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2017
One drug for two targets: Biological evaluation of antiretroviral agents endowed with antiproliferative activityLorenzo Botta, Giorgio Maccari, Pierpaolo Calandro, et al.
Chemmedchem|April 10, 2014
Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693Mattia Mori, Giulia Vignaroli, Ylenia Cau, et al.
Scientific Reports|February 23, 2016
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug deliveryGiulia Vignaroli, Pierpaolo Calandro, Claudio Zamperini, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancers|October 13, 2021
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical ModelsLisa Gherardini, Giovanni Inzalaco, Francesco Imperatore, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2Mario Acunzo, Giulia Romano, Dario Palmieri, et al.
Autophagy|November 14, 2017
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2BDavid Colecchia, Mariangela Stasi, Margherita Leonardi, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Biomaterials Science|March 10, 2026
Nanocellulose with dual carboxy and aldehyde functionality: a modular platform for hydrogel formation and sustained drug releaseEmanuela Bua, Chiara Spanu, Giovanni Inzalaco, et al.
Oncotarget|March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumorsMatteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Journal of Medicinal Chemistry|May 5, 2017
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain BarrierIlaria Monaco, Simona Camorani, David Colecchia, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2017
One drug for two targets: Biological evaluation of antiretroviral agents endowed with antiproliferative activityLorenzo Botta, Giorgio Maccari, Pierpaolo Calandro, et al.
Chemmedchem|April 10, 2014
Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693Mattia Mori, Giulia Vignaroli, Ylenia Cau, et al.
Scientific Reports|February 23, 2016
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug deliveryGiulia Vignaroli, Pierpaolo Calandro, Claudio Zamperini, et al.
Pageof 7